Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 42708-194

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 42708-194). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qpharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (42708 194 30 Label)

Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 75 mg, containing 30 capsules. The label includes dosing instructions placeholders, storage instructions to keep at controlled room temperature, and a note that it is a prescription-only medication. The product is labeled by QPharma, Inc.*

FDA Label Image

Figure (Venlafaxine Fig1)

A pharmacokinetic plot showing fold change and 90% confidence intervals for venlafaxine under various special populations including hepatic impairment (cirrhosis, mild, moderate), renal impairment (mild/moderate, hemodialysis), CYP2D6 polymorphism, age over 60, and gender differences. The graph displays changes in analytes venlafaxine and O-desmethylvenlafaxine (ODV) for Cmax and AUC values relative to a reference value, with points distributed along a horizontal axis labeled 'Change relative to the reference value.'*

FDA Label Image

Figure (Venlafaxine Fig2)

A chart showing the fold change and 90% confidence intervals for venlafaxine pharmacokinetic parameters (Cmax and AUC) in the presence of various interacting drugs, including ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The graph plots changes relative to reference values with markers representing Cmax and AUC changes.*

FDA Label Image

Figure (Venlafaxine Fig3)

This is a scatter plot chart showing the fold change and 90% confidence intervals of pharmacokinetic parameters (Cmax and AUC) for various interacting drugs and their analytes relative to a reference value. The x-axis represents the change relative to the reference value, and the y-axis lists interacting drugs such as ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium with their respective analytes and pharmacokinetic metrics.*

FDA Label Image

Chemical Structure (Venlafaxine Str)

Chemical structure of venlafaxine hydrochloride showing the molecular arrangement of its atoms, including a cyclohexanol group, a methoxy-substituted benzene ring, and a dimethylaminoethyl side chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.